Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$40.2M Hold
605,547
6.82% 2
2025
Q3
$40.7M Sell
605,547
-118,644
-16% -$9.39M 5.92% 4
2025
Q2
$63.2M Buy
+724,191
New +$56.8M 6.52% 1
2025
Q1
Sell
-859,627
Closed -$66.9M 68
2024
Q4
$66.9M Hold
859,627
6.89% 4
2024
Q3
$57.6M Buy
859,627
+292,127
+51% +$24M 6.99% 6
2024
Q2
$64.3M Sell
567,500
-16,683
-3% -$2.11M 8.57% 3
2024
Q1
$81M Sell
584,183
-25,679
-4% -$3.23M 11.26% 1
2023
Q4
$75.7M Buy
609,862
+172,013
+39% +$17.6M 10.57% 1
2023
Q3
$40.9M Buy
+437,849
New +$49.4M 7.56% 6

Other funds holding DXCM

MIG Capital's DXCM Position: Q4 2025 in Review

MIG Capital held its DexCom (DXCM) position steady in Q4 2025 at 605,547 shares worth $40.2M. The position accounts for 6.82% of the portfolio, ranked #2.

MIG Capital first reported a position in DXCM in Q3 2023 and has held it in 9 quarters since. The position peaked at $81M in Q1 2024. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • MIG Capital held 605,547 shares of DexCom worth $40.2M as of Q4 2025.
  • MIG Capital left its DexCom share count unchanged in Q4 2025.
  • DexCom made up 6.82% of MIG Capital's portfolio in Q4 2025, its #2 holding.
  • MIG Capital first reported a position in DexCom in Q3 2023 and has held it in 9 quarters since.
  • MIG Capital's DexCom position peaked at $81M in Q1 2024.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on MIG Capital's 13F filing for Q4 2025, filed 17 Feb 2026.